Multidrug-resistant Acinetobacter: Risk factors and outcomes in veterans with spinal cord injuries and disorders
- PMID: 28757086
- PMCID: PMC8580192
- DOI: 10.1016/j.ajic.2017.06.016
Multidrug-resistant Acinetobacter: Risk factors and outcomes in veterans with spinal cord injuries and disorders
Abstract
Background: Multidrug-resistant (MDR) Acinetobacter is a growing concern and has been identified as a serious threat by the Centers for Disease Control and Prevention. However, there is little information on MDR Acinetobacter in individuals with spinal cord injuries and disorders (SCI/Ds). Therefore, the objective of this study was to identify risk factors for, and assess outcomes of, MDR Acinetobacter in veterans with SCI/Ds.
Methods: This was a retrospective cohort study from January 1, 2012-December 31, 2013, using national Veterans Affairs medical encounter and microbiology data.
Results: A total of 773 Acinetobacter cultures were identified in 571 patients, of which 58.9% were MDR. Inpatient culture, sputum and other specimen type, receipt of antibiotics within 90 days before culture date, and pressure ulcers were identified as independent predictors of MDR Acinetobacter. Highest odds of MDR Acinetobacter were seen with previous antibiotic use (odds ratio, 7.27; 95% confidence interval, 2.59-20.54). Thirty-day mortality was 5.3% in this study. Multidrug resistance, previous mechanical ventilation 90 days before the culture, and cancer were all independent risk factors for 30-day mortality.
Conclusions: There should be increased efforts to highlight the importance of antimicrobial stewardship to improve infection control to help limit spread of Acinetobacter in health care settings.
Keywords: 30-day mortality; Acinetobacter; Epidemiology; Multidrug resistance; Risk factors; Spinal cord injury; Veterans Affairs.
Published by Elsevier Inc.
Comment in
-
Response to letter on "Multidrug-resistant Acinetobacter: Risk factors and outcome in veterans with spinal cord injuries and disorders".Am J Infect Control. 2018 Jul;46(7):849. doi: 10.1016/j.ajic.2018.01.026. Epub 2018 Mar 16. Am J Infect Control. 2018. PMID: 29555146 No abstract available.
-
Comments on Multidrug-resistant acinetobacter: Risk factors and outcomes in veterans with spinal cord injuries and disorders.Am J Infect Control. 2018 Jul;46(7):848-849. doi: 10.1016/j.ajic.2018.01.029. Epub 2018 Apr 9. Am J Infect Control. 2018. PMID: 29650488 No abstract available.
References
-
- Centers for Disease Control. Antibiotic resistance threats in the United States, 2013. Last accessed 8 Aug 2016.
-
- Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME. Predictors of mortality in patients with infections due to multi-drug gram negative bacteria: The study, the patient, the bug or drug? J Infect 2013; 66: 401–14. - PubMed
-
- Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbial Infect 2012; 18(3):268–81. - PubMed
-
- Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network (NHSN( Team and Participating NHSN Facilites. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013; 34(1):1–14. - PubMed
-
- Evans CT, LaVela SL, Weaver FM, Priebe M, Sandford P, Niemiec S, Miskevics S, Parada JP. Epidemiology of hospital-acquired infections in veterans with spinal cord injury and disorder. Infect Control Hosp Epidemiol 2008; 29(3):234–42. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
